ALXN stock: buy or sell
Jan 18th, 2021
ALXN stock brief
- Alexion Pharmaceuticals stock merely moved 0.03% to close at $156.70 on the stock market today, after 3 consecutive sessions in positive.
- Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products.
Should I buy Alexion Pharmaceuticals stock?
Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $ALXN stock a buy?
In the current situation of Alexion Pharmaceuticals there is not any eligible buy setup. This doesn't mean $ALXN will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems
Should I sell Alexion Pharmaceuticals stock?
Knowing when to sell a stock is even harder than knowing when to buy it. In the same way as when we have to buy shares, determining when is appropiate to sell is not a random decision, and we must use our own trading strategy. Our trading system selects very simple strategies to guide us on when is the best time to sell our shares. Be aware that these strategies are not intended for selling short $ALXN stock
A guiding principle is that you should not keep an investment that shows a greater losses than those expected upon the buy. The timing to sell your stock should always be dictated by the stop-loss (automatic or manual)
Is it time to sell Alexion Pharmaceuticals stock?
In the current situation of Alexion Pharmaceuticals there is not any eligible sell setup, so Alexion Pharmaceuticals stock holders with operations in profit can keep their positions
Alexion Pharmaceuticals ratings
In the last 30 days, just one analyst rating was published for Alexion Pharmaceuticals
|Jan 8th, 2021|
Alexion Pharmaceuticals stock analysis
Supports and resistances
The current resistance levels are:
The current support levels are:
The evolution of the Bollinger Bands on the chart reveals that they are relatively close to each other (3.70%), which clearly indicates that price volatility is low. The compression of the Bollinger bands is often a indication of a sudden price movement (up or down), so we must be alert and manage our buy or sell orders appropiately
Relative strength index
The RSI dropped below the overbought level of 70 last Tuesday after just crossing to the overbough zone for 1 day (weak signal). The RSI value last Friday was 68.98. Since then, Alexion Pharmaceuticals price just moved a 0.13%
Alexion Pharmaceuticals stock price history
Alexion Pharmaceuticals started trading priced at an adjusted price1 of $2.25 on Feb 1996. Since then, ALXN stock has risen by 6,864.44%, with an average of 286.02% per year. If you had invested $1,000USD in Alexion Pharmaceuticals stock at that time, it would be valued $69,644.44 today.
1: Adjusted price after possible price splits or reverse-splits
Price target for Alexion Pharmaceuticals stock
Nobody knows how much a share will be priced tomorrow. However, many stock price predictions are published every day by banks, financial institutions and independent analysts.
The following table shows the price forecasts released by brokerage institutions over the last 30 days. Again, these targets are not direct recommendations for individual traders and must not be followed blindly.
We don't have any target price posted in the last month for Alexion Pharmaceuticals.
|Brokerage firm||Price target|
|Jan 8th, 2021|
|Raymond James||Not available|
Earnings and financials
Alexion Pharmaceuticals ($ALXN) hosted the shareholders event and posted the report last October. ALXN presented earnings of $3.24 per share on sales of $1.6 billion. The market estimate was $2.58 per share on revenue of $1.4 billion.In comparison, the EPS for the same quarter last year was $2.79, so posted EPS means a gain of 16.13%. Looking at revenue, figures skyrocketed a 25.78% compared to $12.6B same quarter 12 months ago.
ALXN ($ALXN) is hosting the quarterly earnings call on Thursday next week. Market analysts analysts expect of $2.56, that is a 20.99% lower than previous quarter.
Alexion Pharmaceuticals performance
|Alexion Pharmaceuticals ($ALXN)||-1.90%||29.50%||42.70%|
Important:The opinions written in this post are personal and not recommendations for you to buy or sell stocks. The author of this report does not have any knowledge of the particular circumstances of the reader, his or her own finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are expressed for learning reasons only
|Friday, January 15th, 2021|
|Day range||$156.42 - $157.5|
|Average true range||$2.32|
|50d mov avg||$137.96|
|100d mov avg||$126.49|
|200d mov avg||$116.27|
|Earnings date||January 28th, 2021|